USAQ (QHSLab) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 26, 2026)


USAQ QHSLab Inc USAQ
44 GF Score
Price $0.27
GF Value $0.19
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is QHSLab Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

QHSLab's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.


USAQ vs POAS, TNON, AIDX: Margin of Safety % (DCF Earnings Based) Comparison

For the Medical Devices subindustry, QHSLab's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


QHSLab Margin of Safety % (DCF Earnings Based) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, QHSLab's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where QHSLab's Margin of Safety % (DCF Earnings Based) falls into.


USAQ
44GF Score
QHSLab Inc USAQ
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is QHSLab (USAQ) Overvalued in 2026?

Based on GuruFocus' analysis, QHSLab stock appears to be overvalued. The current stock price of $0.27 is trading 39.5% above its estimated GF Value™ of $0.19. GuruFocus considers QHSLab to be Significantly Overvalued.

Key valuation signals for USAQ:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: $0.19 vs. price of $0.27 (39.5% above fair value)
  • GF Score™: 44/100 with 3 warning signs

No single metric tells the full story. See the USAQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


QHSLab Business Description

Address 901 Northpoint Parkway, Suite 302, West Palm Beach, FL, USA, 33407
QHSLab Inc is a medical device company providing digital healthcare solutions and point-of-care-diagnostic tests to primary care physicians. The company is a medical device technology and software as a service (SaaS) company focused on enabling primary care physicians (PCPs) to increase their revenues by providing them with relevant, value-based tools to evaluate and treat chronic disease as well as provide preventive care through reimbursable procedures.
44GF Score

Get the complete analysis for USAQ

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.27
Price
$0.19
GF Value